175 related articles for article (PubMed ID: 22098438)
1. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort.
Craig WY; Ledue TB
Clin Chem Lab Med; 2011 Nov; 50(3):497-502. PubMed ID: 22098438
[TBL] [Abstract][Full Text] [Related]
2. The antinuclear antibody assay: developing criteria for reflexive anti-dsDNA antibody testing in a laboratory setting.
Craig WY; Ledue TB
Clin Chem Lab Med; 2011 Jul; 49(7):1205-11. PubMed ID: 21612543
[TBL] [Abstract][Full Text] [Related]
3. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
4. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
Kang I; Siperstein R; Quan T; Breitenstein ML
Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
[TBL] [Abstract][Full Text] [Related]
5. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
6. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer.
González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC
Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604
[TBL] [Abstract][Full Text] [Related]
7. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
9. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
11. The Frequency of Immunofluorescence Antinuclear Antibody Patterns and Extractable Nuclear Antigen: Experience From a Large Laboratory in Pakistan.
Imran K; Loya A; Hameed M; Siddiqui IA; Sheikh UN
Cureus; 2023 Jan; 15(1):e33343. PubMed ID: 36751152
[TBL] [Abstract][Full Text] [Related]
12. Anti-ENA antibody profiles in patients with hepatitis C virus infection.
Litwin CM; Rourk AR
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28605141
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus.
Verdelli A; Coi A; Marzano AV; Antiga E; Cozzani E; Quaglino P; La Placa M; Benucci M; De Simone C; Papini M; Parodi A; Bianchi F; Caproni M
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):742-752. PubMed ID: 29924416
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
15. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
16. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
17. Association between antinuclear antibodies (ANA) patterns and extractable nuclear antigens (ENA) in HEp-2 cells in patients with autoimmune diseases in Riyadh, Saudi Arabia.
Alsubki R; Tabassum H; Alfawaz H; Alaqil R; Aljaser F; Ansar S; Al Jurayyan A
Intractable Rare Dis Res; 2020 May; 9(2):89-94. PubMed ID: 32494555
[TBL] [Abstract][Full Text] [Related]
18. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
Peene I; Meheus L; Veys EM; De Keyser F
Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
[TBL] [Abstract][Full Text] [Related]
19. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to the extractable nuclear antigens (ENA) in Pakistani patients with systemic rheumatic disease.
Ahmed TA; Malik IA; Saleem M; Khan AA; Hameed A; Shah ST; Amin SJ; Farooqi A
J Pak Med Assoc; 1995 Jan; 45(1):12-4. PubMed ID: 7731078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
